Richa Poddar

Ms. Poddar joined Agios in 2016 and became chief commercial officer in December 2021. She previously served as senior vice president, corporate strategy and business development; vice president, transition lead oncology programs; head of the oncology portfolio and head of marketing. In these capacities, Ms. Poddar played an important role in shaping Agios’ oncology portfolio, providing strong cross-functional and strategic program leadership, driving the preparation for and launch of the company’s first two approved products and leading the transition of the company’s oncology assets to Servier. Prior to joining Agios, she worked in marketing at Clovis Oncology and spent eight years at Genentech and F. Hoffman La-Roche where she held roles of increasing responsibility, including marketing and market analytics for various oncology products, including Herceptin®, Perjeta®, Kadcyla®, Avastin® and Alecensa®. Prior to Genentech, she worked at Amgen in the commercial analytics group. Ms. Poddar holds a B.E. in computer engineering from Pune University and a Master’s in biotechnology from Keck Graduate Institute in California.